Reports Q1 revenue $810.9M, consensus $797.93M. Eric Evans, Chief Executive Officer, stated, “We are encouraged by our solid start to 2026, with same store revenue growth of 4.4% in line with our Q1 and long-term growth expectations. As we continue to navigate near-term market dynamics, our cost management discipline and continued execution on physician recruitment position us well to meet or exceed our 2026 plan. Our portfolio optimization efforts also remain critical to our long-term strategy as we take steps to better align with our core short-stay surgical operating model. Looking ahead, we are confident in our ability to return to our growth algorithm through capitalizing on market opportunities, driving operational excellence, and thoughtful capital deployment.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGRY:
- Surgery Partners Inc. (SGRY) Q1 Earnings Cheat Sheet
- Surgery Partners price target lowered to $15 from $16.25 at Jefferies
- Ortelius says ‘it’s time for substantial change’ at Surgery Partners
- Surgery Partners price target lowered to $20 from $28 at TD Cowen
- Surgery Partners price target lowered to $17 from $19 at Mizuho
